Loss of TIMP3, the only known physiological inhibitors of ADAM17, is associated with age-related renal fibrosis and tubulointerstitial fibrosis (Kawamoto et al, 2006; Kassiri et al, 2009), which are important prognostic marker in a wide variety of kidney diseases. The gene discussed is ADAM17; the disease is kidney disorder.